<![CDATA[Inotuzumab Ozogamicin Shows MRD Clearance in B-Cell ALL Trial]]>

Phase 2positiveinotuzumab ozogamicinPositive

AI Analysis

Summary

Phase 2 trial data demonstrate that inotuzumab ozogamicin achieves MRD clearance in B-cell acute lymphoblastic leukemia patients, indicating the drug's potential to deepen remissions in this indication.

Clinical Trial Data

Phase

Primary Endpoint

Met

Outcome Details

MRD clearance demonstrated

Importance:6/10

Sentiment:

0.65

oncologyleukemiaphase_2_dataimmunotherapyMRD_clearance

Related Companies

$PFE

Read the original article

Published by Cancer Network on July 8, 2026 2:30 PM

Read Original